MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 31, 2006; DOI: 10.1124/mol.106.026120


0026-895X/06/7005-1630-1642$20.00
Mol Pharmacol 70:1630-1642, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026120v1
70/5/1630    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beuming, T.
Right arrow Articles by Weinstein, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beuming, T.
Right arrow Articles by Weinstein, H.

A Comprehensive Structure-Based Alignment of Prokaryotic and Eukaryotic Neurotransmitter/Na+ Symporters (NSS) Aids in the Use of the LeuT Structure to Probe NSS Structure and Function

Thijs Beuming, Lei Shi, Jonathan A. Javitch, and Harel Weinstein

Department of Physiology and Biophysics, and HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, New York (T.B., L.S., H.W.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York (J.A.J.).

The recently elucidated crystal structure of a prokaryotic member of the neurotransmitter/sodium symporter (NSS) family (Yamashita et al., 2005) is a major advance toward understanding structure-function relationships in this important class of transporters. To aid in the generalization of these results, we present here a comprehensive sequence alignment of all known prokaryotic and eukaryotic NSS proteins, based on the crystal structure of the leucine transporter from Aquifex aeolicus (LeuT). Regions of low sequence identity between prokaryotic and eukaryotic transporters were aligned with the aid of a number of bioinformatics tools, and the resulting alignments were validated by comparison with experimental data. In a number of regions, including the transmembrane segments 4, 5, and 9 as well as extracellular loops 2, 3, and 4, our alignment differs from the one proposed previously [Nature (Lond) 437: 215-223, 2005]. Important similarities and differences among the sequences of NSS proteins in regions likely to determine selectivity in substrate binding and mechanisms of transport regulation are discussed in the context of the LeuT structure and the alignment.


Received May 4, 2006; accepted July 31, 2006

Address correspondence to: Harel Weinstein. Department of Physiology and Biophysics. Weill Medical College of Cornell University. Box 75, Room E-509, 1300 York Ave., New York, NY 10021. E-mail: haw2002{at}med.cornell.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. H. Shrivastava, J. Jiang, S. G. Amara, and I. Bahar
Time-resolved Mechanism of Extracellular Gate Opening and Substrate Binding in a Glutamate Transporter
J. Biol. Chem., October 17, 2008; 283(42): 28680 - 28690.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
M. I. Torres-Altoro, K. J. White, G. J. Rodriguez, D. E. Nichols, and E. L. Barker
Helix XI contributes to the entrance of the serotonin transporter permeation pathway
Protein Sci., October 1, 2008; 17(10): 1761 - 1770.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. R. Forrest, Y.-W. Zhang, M. T. Jacobs, J. Gesmonde, L. Xie, B. H. Honig, and G. Rudnick
Mechanism for alternating access in neurotransmitter transporters
PNAS, July 29, 2008; 105(30): 10338 - 10343.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kniazeff, L. Shi, C. J. Loland, J. A. Javitch, H. Weinstein, and U. Gether
An Intracellular Interaction Network Regulates Conformational Transitions in the Dopamine Transporter
J. Biol. Chem., June 20, 2008; 283(25): 17691 - 17701.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. C. Walline, D. E. Nichols, F. I. Carroll, and E. L. Barker
Comparative Molecular Field Analysis Using Selectivity Fields Reveals Residues in the Third Transmembrane Helix of the Serotonin Transporter Associated with Substrate and Antagonist Recognition
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 791 - 800.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
L. Celik, B. Schiott, and E. Tajkhorshid
Substrate Binding and Formation of an Occluded State in the Leucine Transporter
Biophys. J., March 1, 2008; 94(5): 1600 - 1612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Jacobs, Y.-W. Zhang, S. D. Campbell, and G. Rudnick
Ibogaine, a Noncompetitive Inhibitor of Serotonin Transport, Acts by Stabilizing the Cytoplasm-facing State of the Transporter
J. Biol. Chem., October 5, 2007; 282(40): 29441 - 29447.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y.-W. Zhang, J. Gesmonde, S. Ramamoorthy, and G. Rudnick
Serotonin Transporter Phosphorylation by cGMP-Dependent Protein Kinase Is Altered by a Mutation Associated with Obsessive Compulsive Disorder
J. Neurosci., October 3, 2007; 27(40): 10878 - 10886.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. R. Forrest, S. Tavoulari, Y.-W. Zhang, G. Rudnick, and B. Honig
Identification of a chloride ion binding site in Na+/Cl -dependent transporters
PNAS, July 31, 2007; 104(31): 12761 - 12766.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. A. Paczkowski, I. A. Sharpe, S. Dutertre, and R. J. Lewis
{chi}-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model
J. Biol. Chem., June 15, 2007; 282(24): 17837 - 17844.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Miszner, A. Peres, M. Castagna, S. Bette, S. Giovannardi, F. Cherubino, and E. Bossi
Structural and functional basis of amino acid specificity in the invertebrate cotransporter KAAT1
J. Physiol., June 15, 2007; 581(3): 899 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Dodd and D. L. Christie
Selective Amino Acid Substitutions Convert the Creatine Transporter to a {gamma}-Aminobutyric Acid Transporter
J. Biol. Chem., May 25, 2007; 282(21): 15528 - 15533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ramamoorthy, D. J. Samuvel, E. R. Buck, G. Rudnick, and L. D. Jayanthi
Phosphorylation of Threonine Residue 276 Is Required for Acute Regulation of Serotonin Transporter by Cyclic GMP
J. Biol. Chem., April 20, 2007; 282(16): 11639 - 11647.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Quick and J. A. Javitch
Monitoring the function of membrane transport proteins in detergent-solubilized form
PNAS, February 27, 2007; 104(9): 3603 - 3608.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-W. Zhang and G. Rudnick
The Cytoplasmic Substrate Permeation Pathway of Serotonin Transporter
J. Biol. Chem., November 24, 2006; 281(47): 36213 - 36220.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics